Palamarchuk I. V., Strutynska O. B., Melnyk A. V., Zaichko N. V

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

Diabetes mellitus (DM) is a recent problem due to the high prevalence of the disease and the high mortality of patients. The most common complications of type I and II diabetes include heart and kidney damage. Metformin, as a first-line drug in the treatment of type 2 diabetes, are known to reduce the risk of cardiovascular and renal complications. Recently, metformin has been shown to increase H2 S in the organs of rats, which is a known cardio- and nephroprotector. However, the effect of metformin on H2 S metabolism in the heart and kidneys in experimental diabetes remains uncertain. The ability of H2 S donors to modify the antidiabetic effect of metformin is also unknown. Objective: to evaluate the effect of metformin and its combination with sodium hydrogen sulfide on H2 S system, the content of profibrogenic mediator galectin-3, the activity of free radical oxidation of lipids and proteins in the heart and kidneys of rats with streptozotocin-induced diabetes. Object and methods of research. The experiments were carried out on 40 white laboratory rats of both sexes, weight 220-280 g. DM model was initiated by a single intraperitoneal injection of streptozotocin (40 mg/kg) in three groups of animals. From the 3rd to the 28th day after streptozotocin injection, one group of animals was administered metformin (500 mg/kg) intragastrically once per day, and the other group along with metformin was administered a H2 S donor – NaHS • H2 O (3 mg/kg) once per day intraperitoneally. Peripheral blood glucose was measured using a glucometer, galectin-3 levels were determined by enzyme-linked immunosorbent assay (ELISA) kit in myocardial and renal homogenates, H2 S content, cystathionine-γ-lyase (CGL) activity, levels of malonic dialdehyde (MDA group) and carbonic acid. Statistical processing of the results was performed using SPSS Statistica 17.0. Research results. According to our results, a single injection of streptozotocin caused a number of metabolic disturbances : an increase in blood glucose by 4.6 times (p <0.05), a decrease in H2 S in the myocardium and kidneys by 32.6-35.4% 0.05), a decrease in H2 S synthesis (in the reaction of hydrolytic cleavage of cysteine catalysed be cystathionine-γ-lyase) in 2.2-2.4 times (p <0.05), an increase in galectin-3 in 5-5.5 times (p <0,05) and increase in lipid peroxidation products and protein peroxidation products – MDA and carbonyl groups – in 1.6-2 times (p <0,05) compared to control. In case of metformin administration to rats with experimental DM were registered significantly higher levels of H2 S (25.8-28.6%), the activity of H2 S – synthesizing enzyme cystathionine-γ-lyase (58.1-60.3%), the content of profibrogenic mediator galectin-3 (1.9-2 times) and lower levels of lipid and protein peroxidation products (21-26.6%), compared with untreated animals. In the group of animals treated with the combination of metformin + NaHS, the blood glucose content was significantly lower by 15.5%, the level of galectin-3 in the heart and kidneys – by 2.7-3 times, compared with rats treated with metformin alone. At the same time, the level of H2 S, cystathionine-γ-lyase activity, the content of lipid and protein peroxidation products in the heart and kidneys did not differ significantly from the control group of animals. Conclusions. The administration of metformin to diabetic rats was accompanied by cardio- and nephroprotective effects, which were associated with its hypoglycemic, antioxidant activity, ability to potentiate H2 S metabolism and reduce the expression of profibrogenic mediator galectin-3. The introduction of H2 S donor significantly reinforced these effects of metformin.

streptozotocin diabetes, metformin, hydrogen sulfide, galectin-3, oxidative stress.

1. World Health Organization [Internet]. Available from: www.euro.who.int
2. Tsytovsʹkyy MN. Statystychnyy, klinichnyy ta morfolohichnyy aspekty vplyvu tsukrovoho diabetu na stan sertsevo-sudynnoyi systemy. Naukovyy visnyk Uzhhorodsʹkoho universytetu. Seriya: Medytsyna. 2017;1(55):168-77. [in Ukrainian].
3. Nna VU, Abu Bakar AB, Md Lazin MRML, Mohamed M. Antioxidant, anti-inflammatory and synergistic anti-hyperglycemic effects of Malaysian propolis and metformin in streptozotocin-induced diabetic rats. Food Chem Toxicol. 2018;120:305-20.
4. Zaichko NV, Melnik AV, Yoltukhivskyy MM, Olhovskiy AS, Palamarchuk IV. Hydrogen sulfide: modern aspects of metabolism, biological and medical role. Ukr. Biochem. J. 2014;86(5):5-25.
5. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Opoka W. Metformin raises hydrogen sulfide tissue concentrations in various mouse organs. Pharmacol Rep. 2013;65(3):737-42.
6. Okamoto M, Yamaoka M, Takei M, Ando T, Taniguchi S, Ishii I, et al. Endogenous hydrogen sulfide protects pancreatic beta-cells from a high-fat diet-induced glucotoxicity and prevents the development of type 2 diabetes. Biochem Biophys Res Commun. 2013;442(3-4):227- 33.
7. Spasov AA, Petrov VI, Cheplyayeva NI, Lenskaya KV. Fundamental’nyye osnovy poiska lekarstvennykh sredstv dlya terapii sakharnogo diabeta 2-go tipa. Vestnik Rossiyskoy akademii meditsinskikh nauk. 2013;68(2):43-9. [in Russian].
8. Verma S, Yao L, Dumont AS, McNeill JH. Metformin treatment corrects vascular insulin resistance in hypertension. J Hypertens. 2000;18(10):1445-50.
9. Voloshchuk N, Taran I. Аcute toxicity of hydrogen sulfide and its influence on the antiinflammatory effect of diclophenac in experiment. Medical and Clinical Chemistry. 2011;13(4):88-90.
10. Wiliński B, Wiliński J, Somogyi E, Piotrowska J, Góralska M. Amlodipine affects endogenous hydrogen sulfide tissue concentrations in different mouse organs. Folia Med Cracov. 2011;51(1-4):29-35.
11. Zaichko NV, Pentyuk NO, Melʹnyk AV, Shtatko EI, Andrushko II. Utvorennya hidrohen sulʹfidu v orhanakh shchuriv. Medychna khimiya. 2009;11(4):7-13. [in Ukrainian].
12. Ohkawa H, Ohishi N, Vagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analyt. Biochem. 1979;95(2):351-8.
13. Zaichko NV. Okyslyuvalna modyfikatsiya bilkiv syrovatky krovi yak marker aktyvnosti revmatoyidnoho artrytu ta yiyi zminy pid vplyvom farmakoterapiyi amizonom, indometatsynom, nimesulidom. Visnyk Vinnyts’koho derzhavnoho medychnoho universytetu. 2003;7(2/2):664- 6. [in Ukrainian].
14. Kochetov GA. Prakticheskoe rukovodstvo po enzimologii. Moskva: Vysshaya shkola; 1980. s. 223-4. [in Russian].
15. Charytan DM, Solomon SD, Ivanovich P, Remuzzi G, Cooper ME, McGill JB, et al. Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease. Diabetes Obes Metab. 2019;21(5):1199-208.
16. Kundu S, Pushpakumar S, Khundmiri SJ, Sen U. Hydrogen sulfide mitigates hyperglycemic remodeling via liver kinase B1-adenosine monophosphate-activated protein kinase signaling. Biochim Biophys Acta. 2014;1843(12):2816-26.
17. Gheibi S, Jeddi S, Kashfi K, Ghasemi A. Effects of Hydrogen Sulfide on Carbohydrate Metabolism in Obese Type 2 Diabetic Rats. Molecules. 2019;24(1):190. DOI: 10.3390/molecules24010190

«Bulletin of problems biology and medicine» Issue 3 (157), 2020 year, 133-137 pages, index UDK 546.22-02:616.379-008.64:616.12:616.61

10.29254/2077-4214-2020-3-157-133-137